Spinal Tech

The spine and orthopedic medtech landscape was defined by a flurry of deals in the early weeks of 2025.

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. 

On Jan. 29, Fortune released its annual list of the World's Most Admired Companies, including several healthcare companies from medical facilities, to insurers to medical equipment manufacturers. 

Life Spine earned FDA 510(k) clearance for its ProLift Pivot expandable spacer system, according to a Jan. 29 news release. 

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company "better align" its resources, CEO Kevin Lobo said in a Jan. 28 earnings call.

From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22. 

Stryker's CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO, according to a Jan. 28 news release.

Stryker plans to sell its U.S. spinal implants business, the company said Jan. 28.

Stryker's net sales grew to $6.4 billion in the fourth quarter of 2024, and full-year revenue increased, according to financial results posted Jan. 28.

The Miami Project to Cure Paralysis and the Department of Neurological Surgery at the University of Miami (Fla.) Miller School of Medicine is the second U.S. site to join Neuralink's PRIME study, according to a Jan. 27 news release.